Edition:
United Kingdom

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

2.73USD
21 Feb 2019
Change (% chg)

-- (--)
Prev Close
$2.73
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
42,331
52-wk High
$11.09
52-wk Low
$1.85

Chart for

About

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)

Overall

Beta: -0.71
Market Cap(Mil.): $25.24
Shares Outstanding(Mil.): 14.43
Dividend: --
Yield (%): --

Financials

  DFFN.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.86 -- --
ROI: -143.79 8.92 14.45
ROE: -221.11 10.08 15.96

Earnings vs. Estimates